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ABSTRACT
Psychosocial care has been shown to improve psychological and physiological
functioning in cancer patients. However, as few as five percent of cancer patients
engage in psychosocial care. Therefore, Study 1 of this dissertation developed
measures of core TTM constructs (Stage of Change, Decisional Balance, SelfEfficacy) relevant for increasing engagement in psychosocial care among individuals
diagnosed with cancer.
Measure development entailed qualitative methods for item development and
refinement followed by a series of quantitative analyses. The Stage of Change measure
was validated against external constructs such as subjective present and future wellbeing. As expected, a chi-square test indicated that individuals in Action and
Maintenance were significantly more likely to be in treatment than those in the preAction stages.
Measures for Decisional Balance and Self-Efficacy were developed using splithalf, cross-validation procedures. In these, a series of Principal Component Analyses
(PCAs) were conducted with half of the sample to narrow the item set and explore
factor structure, and Confirmatory Factor Analyses (CFA) were conducted on the
second half of the sample to confirm the factor structure and item loadings. For
Decisional Balance, PCA supported two, 8-item factors, and CFA indicated a twofactor correlated model was the best fit to the data. For Self-efficacy, PCA supported
two, 3-item factors, and CFA further supported this structure. Multivariate analyses
indicated significant stage-construct relationships.

Overall results supported the validity of the measures developed and laid the
foundation for applying the TTM to psychosocial treatment acceptance among cancer
populations. Implications for application of the TTM to cancer populations are
discussed.
Given that cancer patients frequently experience considerable distress during
diagnosis and treatment, Study 2 described the development and utilization of a
behavioral health program for cancer patients, at a small community hospital, as well
as provided preliminary results on program efficacy. This program was co-developed
by individuals from a university-based clinical psychology doctoral program and a
community hospital. The behavioral health program was comprised of a licensed,
PhD-level clinical psychologist and seven clinical psychology doctoral students, who
met with patients in order to accrue clinical hours. Patients were typically referred by
their oncologists or nurses. Distress, depression, and anxiety were evaluated for a
small subsample of participants. From the time the program was initiated, 238 patients
between ages 18 and 95 (M = 66.4) were evaluated over a three-year period. The
majority of patients (77.8%) were offered psychosocial care. Although 49.8% declined
treatment, 23.6% engaged in one session and 26.6% engaged in two or more. Patients
who were referred through the STAR Program® were more likely to engage in
psychosocial care than those who found out about behavioral health through other
means.
First, distress tracking may be improved if nurses, oncologists, and behavioral
health providers administer measures. Second, partnerships between clinical
psychology doctoral programs and hospitals may be mutually beneficial. Third,

hospitals offering cancer treatment may benefit from obtaining STAR® certification,
in order to generate referrals for comprehensive cancer care. These efforts can serve as
a model for other hospitals seeking to integrate behavioral health into routine cancer
treatment.
Together, these two studies address the scarcity of studies on the intersection of
cancer and mental health. As such, this work aimed to bridge the gap between the two
disciplines, in order to prevent and treat mental health problems in cancer patients.
Results of Study 1 may be used to guide researchers and clinicians in designing and
implementing interventions. Study 2 methods and findings may be used to develop
other behavioral health programs and to benchmark other integration efforts.
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Abstract
PURPOSE: Cancer is one of the most physically and emotionally debilitating diseases.
Despite evidence that psychosocial care can improve psychological and physiological
functioning, as well as increase survival rates, as few as 4.4% are willing to engage in
psychosocial treatment. This study evaluated readiness to engage in psychosocial
treatment by developing measures of Stage of Change, Decisional Balance, and SelfEfficacy. METHODS: Online survey data was collected from a national sample of 475
adults (Mage = 47.89, SD = 14.77) with cancer diagnoses. RESULTS: For Decisional
Balance, PCA indicated two, 8-item factors (Pros α = .93; Cons α = .81). CFA
supported a two-factor correlated model, χ2(103) = 349.563, p < .001, CFI = .928,
RMSEA = .075. For Self-Efficacy, PCA indicated two, 3-item factors (“physical” and
“social/emotional”; α = .83). CFA supported this structure. Multivariate analyses
indicated significant cross-stage differences for Pros, Cons, and Self-Efficacy.
CONCLUSION: Findings support the validity of the developed Stage of Change,
Decisional Balance, and Self-Efficacy measures. These measures may be used to
evaluate readiness to engage in psychosocial care for cancer patients and survivors –
and to tailor interventions to help them progress through the stages.

Keywords: cancer, psychosocial, readiness, TTM, stages of change, self-efficacy,
decisional balance
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As of January 1, 2014, approximately 14.5 million Americans had a history of
cancer. In addition, the National Cancer Institute (NCI) of the National Institutes of
Health (NIH), as well as the American Cancer Society (ACS) estimated 1.7 million
new cancer cases in 2016. Notably, it is estimated that the cancer survivor population
will increase to 19 million by January 1, 2024 [1], while the World Health
Organization [2] predicted a 70% increase over the next two decades, worldwide.
Although cancer incidence is expected to increase, the cancer death rate in the United
States decreased by 23% between 1990 and 2012 [1]. Given the rise in cancer cases
and the growing survivor population, there will also be increasing physical and
emotional concerns associated with the disease and its treatment [3,4]. The
multidimensional burden (i.e., vocational, financial, physical, interpersonal) of cancer
undeniably makes it one of the most emotionally debilitating conditions [5].
The relationship between the physical and emotional burden of cancer is
evidently strong [5-8]. For instance, depression has been shown to increase the length
of hospitalization in lung cancer patients undergoing thoracic surgery [9]. Further, in a
sample head and neck cancer patients, quality of life and negative coping styles were
related to higher levels of anxiety and depression, as well as lower levels of optimism
[10]. Remarkably, a 10-year study of 3,080 cancer survivors revealed that those with
depression had double the risk of all-cause mortality, compared to those without
depression [11]. Collectively, these findings reveal the pervasiveness of mental health
issues among cancer patients, their staggering impact on physiological outcomes [9],
survival rates [12], and accordingly, the need to address psychological concerns [10].
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Psychosocial interventions, particularly in the form of evidence-based
treatments and support groups, have been used to address a variety of cancer-related
concerns, including quality of life [13,14], fatigue [15], pain [16], depression [17-19],
and anxiety [20]. Further, psychosocial care may be used for increasing resilience and
confidence, as well as for addressing fear of tumor progression [21]. Overall, this
growing body of research has demonstrated effects largely in favor of psychosocial
care.
Physiological outcome data further strengthens the case for psychosocial care
among cancer patients. For instance, a seminal study revealed the effect of
psychosocial treatment on survival of metastatic breast cancer patients, such that those
who had participated in a support group were more likely to be survivors eight months
after the intervention [22]. Notably, a more recent study revealed that pre-operative
stress management improved immune functioning in men with prostate cancer
undergoing radical prostatectomy [23]. Further, several studies found that
psychosocial interventions were helpful in slowing disease progression [24-26] and
increasing survival in cancer patients [27]. Collectively, studies support the potential
for psychosocial interventions to improve cancer patients’ physiological profile.
Numerous studies have explored the mechanisms and processes underlying the
impact of psychosocial care on cancer patients’ physiological functioning. For
instance, a recent review of 16 randomized controlled trials (RCTs) that examined
specific therapeutic components of treatments tailored for cancer patients revealed that
alterations in cognitions, self-efficacy, mood disturbance, pain, and self-esteem were
most important [28]. An earlier study established correlations between verbal or
4

written expressions of emotions and levels of tumor-infiltrating cancer lymphocytes in
melanoma, suggesting that psychosocial interventions can enhance emotional
expression to positively affect disease course and overall physiological functioning
[26]. Similarly, Jensen discovered that repression of negative emotions was associated
with an aggravated course of breast cancer and that psychological variables were twice
as effective at predicting clinical outcomes as were biological indicators [29].
Psychosocial interventions can also improve adherence to various difficult cancer
treatments, which can increase survival. Altogether, compelling evidence exists for the
role that psychosocial interventions may play in cancer patients’ physiological
profiles.
Despite overwhelmingly strong evidence that psychosocial interventions
improve psychological and physiological well-being in cancer patients, reluctance to
accept psychosocial treatment prevails. For example, a study of 132 cancer patients
revealed that only 28% participated in psychosocial support, with 88% of respondents
being women with a history of breast cancer (72%). However, those who utilized
support had positive attitudes towards therapeutic interventions and a desire to cope
more effectively with their illness [30]. A recent study of 1,777 cancer survivors
revealed that only 4.4% used psychosocial care and alarmingly, the majority (55.1%)
never even discussed the possibility with their oncologists. Interestingly, the 4.4% that
used psychosocial services reported high satisfaction with how their needs were
addressed [31]. In light of these findings, treatment engagement strategies are needed,
particularly by way of assessing readiness to change and developing interventions.
The Transtheoretical Model (TTM) has been found effective in assessing
5

readiness to change and in guiding interventions [32]. The TTM is an integrative and
comprehensive model of intentional behavior change that incorporates processoriented variables to explain and predict how and when individuals change. TTMguided interventions have modified many health risk behavior changes, including
adherence to medical protocols and treatments, such as mammography screening [33],
medications [34, 35], blood glucose monitoring [37], and blood donation [36].
Therefore, it offers a promising theoretical framework for assessing readiness to
accept psychosocial care for cancer populations.
Key TTM constructs include Stage of Change, Decisional Balance, and SelfEfficacy. Stage of Change is the central organizing construct of the TTM, representing
the temporal and readiness dimensions. As people change, they make forward stage
progress through five identified stages: Precontemplation, Contemplation, Preparation,
Action, and Maintenance. Accurately assessing Stage of Change is integral to the
design and delivery of tailored behavior change interventions. Further, readiness to
change is, in part, based on Decisional Balance. With regard to Decisional Balance, a
stable pattern has been identified across Stages of Change for 48 different health risk
behaviors [38]. For example, Cons are more salient than Pros in Precontemplation,
whereas Pros are more salient than Cons in the Maintenance stage. Finally, SelfEfficacy is defined as one’s level of confidence to successfully change a target
behavior across challenging situations. Self-Efficacy scores are higher in later Stages
of Change, such as those in Precontemplation reporting less confidence than those in
Action or Maintenance [39]. As a result, Stage of Change, Decisional Balance, and
Self-Efficacy may be used jointly to predict and facilitate behavior change.
6

In light of previous research findings on cancer patient reluctance to utilize
psychosocial care, assessing readiness to change is clearly warranted. Although
previous studies have explored barriers [40] and readiness to utilize psychosocial
treatment [41], this is the first study to apply the TTM and quantitative methodology
to acceptance of psychosocial care among cancer patients. As such, using the TTM as
a theoretical framework and developing measures for acceptance of psychosocial care
may enhance treatment engagement and advance models of team-based cancer
treatment approaches. Thus, this study assessed three TTM constructs (Stage of
Change, Decisional Balance, and Self-Efficacy) to accepting psychosocial care as a
part of one’s cancer treatment plan. The present study developed TTM measures that
can be used to engage cancer patients in psychosocial care and to guide team-based
interventions.
METHODS
Design
A sequential process of measure development was used to develop measures of
Stages of Change, Decisional Balance, and Self-efficacy [42]. A series of semistructured expert and research participant interviews were conducted. Item
development was followed by exploratory, confirmatory, and external validation
analyses.
Item Development
Initial item development was based on a comprehensive review of TTM
measures for other behaviors (e.g., physical activity, high-fat diet, cigarette smoking).
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Items were further developed from the literature on psychooncology and
psychotherapy.
Expert Interviews
Following initial development, items were refined using feedback from experts
in behavioral health, oncology, and the TTM. First, one licensed psychologist and
PhD-level expert in working with cancer patients in a team-based oncology setting
participated in a semi-structured interview on issues surrounding patient engagement
in psychosocial care and provided feedback on the proposed set of items. Next, two
oncologists provided feedback on issues that cancer patients commonly face with
regard to diagnosis and treatment, as well as barriers to engaging in psychosocial care.
Finally, two PhD-level experts in the TTM reviewed the proposed set of items for
clarity and face validity.
Qualitative Participant Interviews
After expert feedback was incorporated, 12 semi-structured qualitative
interviews were conducted with cancer patients actively recruited from a community
hospital. The goal of these interviews was to elicit feedback on item clarity,
acceptability, and face validity. Participants had to be over the age of 18 and had to
have a cancer diagnosis. All interviews were conducted in private patient rooms, while
individuals were receiving chemotherapy. Participants reviewed and signed informed
consent forms first. No participants withdrew from the study after reviewing informed
consent. Participants then reviewed and completed the initially developed items and
provided oral feedback. Participant feedback was discussed with the TTM experts and
was incorporated to generate the final version of the survey.
8

Survey Administration
The survey was administered using SurveyMonkey™ online survey software.
Participants accessed the survey via an online link provided by Cint™, a targeted
survey population and panel recruitment company. Individuals were asked to check a
box indicating that they read the informed consent form and agreed to participate.
They were then routed to questions on eligibility criteria (same as those for qualitative
interviews). Eligible individuals were then linked to the full survey. Data were
extracted from SurveyMonkey™ into SPSS for exploratory analyses and to EQS for
confirmatory analyses.
Sample
Recruitment
Participants for qualitative interviews were recruited in person, by the primary
investigator, at the Infusion Therapy Department at a community hospital. Interested
participants were presented with informed consent forms to engage in semi-structured
interviews and to provide oral feedback on the initially developed set of items. Of the
13 individuals offered to participate, 12 expressed interest. Qualitative interview
participants were not compensated for their participation.
During the online survey administration phase of the study, participants were
recruited through Cint™. Eligibility criteria were added to ensure a census-balanced
sample, with adequate representation across specific groups and geographic regions in
the United States. Eligibility quotas were as follows: only patients with a history of
cancer (100%), males (n = 233), females (n = 242), ages 18-22 (n = 43), ages 23-35 (n
= 114), ages 36-55 (n = 185), ages 56-80 (n = 133), Midwest (n = 109), Northeast (n =
9

90), South (n = 171), and West (n = 105). All recruitment and human subjects
procedures were approved by the [masked for anonymous review] and [masked for
anonymous review] institutional review boards.
Qualitative Interview Sample
Twelve, one-on-one, qualitative interviews were conducted by a clinical
psychology doctoral student. The average age of the participants was 65.5 (SD = 10.9)
and all participants had a present cancer diagnosis. Seven of the participants identified
as female and five identified as male. All 12 participants identified as White.
Measures
Measures Used
Cantril Self-Anchoring Striving Scale. The Cantril Self-Anchoring Striving Scale [43]
was used to determine evaluative well-being outcomes. Individuals were asked to rate
their current and future lives on a ladder scale from 0 to 10, in which 0 represented the
worst possible life and 10 represented the best possible life. The first question aims to
capture present subjective well-being: “Please imagine a ladder with steps numbered
from 0 at the bottom, to 10 at the top. The top of the ladder represents the best possible
life for you, and the bottom of the ladder represents the worst possible life for you. On
which step of the ladder would you say you personally feel you stand at this time?”
The second question aims to capture future subjective well-being: “On which step do
you think you will stand about five years from now?” Individuals who rated their
present lives a 7 or higher and their future lives an 8 or higher were classified as
“thriving”. Individuals who rated their current lives a 4 or lower and their future lives
a 4 or lower were classified as “suffering”. Individuals who met neither of these
10

criteria were classified as “struggling” (e.g., rated their current lives as 5 and future
lives as 6).
Measures Developed
Stage of Change for Psychosocial Care. Participants were assigned to a Stage of
Change based on their answers to a short series of questions. They were assigned to
the Precontemplation stage if they indicated that they were not considering
psychosocial care and did not intend to engage in it for the next 6 months; to
Contemplation if they intended to seek psychosocial care within the next 6 months;
and to Preparation if they intended to seek psychosocial care within the next 30 days.
Participants were assigned to the Action stage if they were receiving psychosocial care
and had been for less than 6 months, and Maintenance if they had been receiving
psychosocial care for 6 months or more.
Decisional Balance for Psychosocial Care. Thirteen items represented the Cons and
eight items reflected the Pros. Respondents indicated how important each item was in
their decisions of whether to accept psychosocial care, on a 5-point Likert scale,
ranging from 1 = ‘Not Important At All’ to 5 = ‘Extremely Important’.
Self-efficacy. Nine items assessed Self-efficacy. Items evaluated participants’
confidence in their ability to engage in psychosocial care across a variety of
challenging situations (e.g., feeling fatigued after chemotherapy). Participants
indicated their confidence levels on a 5-point Likert scale, ranging from 1 = “Not At
All Confident” to 5 = “Extremely Confident”.
Data Analysis
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Data were examined for violations of normality before exploratory and
confirmatory analysis. A random half of the sample was used for the exploratory
phase using principal components analysis (PCA) with varimax rotation on item
correlation matrixes. PCAs determined the number of components and reduced scales
to a smaller set of items. The number of components retained was based on the
minimum average partial procedure (MAP) and parallel analysis [44, 45]. Item
selection was an iterative process that involved removing items for quantitative
reasons (loadings <.40, or > .90 and correlations >.70 with other items, or high
loadings [>.40] on multiple factors) and qualitative breadth of construct (to avoid
redundancy and maintain conceptual breadth). The overall Cronbach alpha was
examined to determine scale internal consistency.
The second half of the sample (n = 238) was used for confirmatory factor
analysis (CFA). CFAs were used to evaluate the degree to which an independent
portion of the data fit the model created by iterative PCAs. Model fit and factor
loadings were evaluated. Final item selection was determined on the basis of item
clarity, lack of redundancy, and conceptual breadth. Finally, Cronbach alphas and rho
coefficients were examined to determine scale internal consistency. In the final phase,
external validation analyses were conducted with the full sample (N = 475). First, the
relationship between TTM constructs and Stages of Change was evaluated and
compared to patterns seen in other areas of behavior change (Figures 1-3). Raw TTM
construct scores (see Table 4) were translated to T-scores and weighted by group size
to eliminate bias created by uneven Stage groups.
A chi-square test evaluated the association between participants’ mental health
12

treatment status (in treatment versus not in treatment) and Stage of Change for
Psychosocial Care. ANOVA also evaluated the relationship between Self-Efficacy and
Stage of Change. Next, MANOVA evaluated relationships between Decisional
Balance and Stage of Change. ANOVA determined whether individuals in the
Action/Maintenance stages of change showed different levels of well-being than those
in pre-Action stages. Then, regression analyses evaluated relationships between TTM
constructs and subjective well-being. Finally, relationships between constructs were
evaluated for consistency with patterns seen for other behaviors (e.g., physical
activity, cigarette smoking).
RESULTS
Survey Sample
Cint ™ recruited 466 eligible adults to participate in the online survey portion
of the study (sample demographics are summarized in Table 1). The sample was
primarily female (54.6%, n = 255), and ages ranged from 18 to 78 (M = 47.89, SD =
14.77). The majority (79%) of the sample was White (n = 368), 6.9% (n = 32) was
multiracial or multiethnic, 4.9% (n = 23) was Hispanic/Latino, 4.1% (n = 19) was
Black, 1.9% (n = 9) was Asian, 1.9% (n = 9) was American Indian/Native American,
and 0.9% classified themselves as not fitting any of the aforementioned racial
categories (n = 4). The majority of the sample (47.8%, n = 223) was in
Precontemplation. Approximately one-fifth (22.1%, n = 103) were in Contemplation,
8.1% (n = 38) were in Preparation, 8.6% (n = 40) were in Action), and 13.5% (n = 63)
in Maintenance.
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In addition to sociodemographic information, self-reported medical
information was collected. The most common cancer diagnoses were: breast (16.8%),
prostate (7%), cervical (5.1%), thyroid (4.9%), and skin-basal squamous cell (4.9%).
Further, 23.4% of the sample reported multiple cancer diagnoses, as a result of
metastasis. Given that 57 different cancer diagnoses were reported, variables were
recoded such that diagnoses were organized according to organ system/site (e.g.,
gastrointestinal, gynecologic, skin), as presented by the National Cancer Institute
(2016). Additional information regarding the sample’s cancer diagnoses and treatment
may be found in Table 2.
Stages of Change
Descriptive Results
A series of chi-square tests of independence revealed relationships between
Stage of Change and demographic variables. A chi-square test did not support an
association between gender and stage, χ2 (4, n = 461) = 7.64, p = .12, phi = .12 or
between race and stage, χ2 (4, n = 461) = 7.36, p = .12, phi = .13. However, a chisquare test revealed an association between identifying as Hispanic/Latino and being
in a pre-Action stage, χ2 (4, n = 460) = 31.37, p < .001, phi = .26. Additionally, chisquare tests revealed no association between stage and level of education [χ2 (4, n =
461) = 3.47, p = .48, phi = .09]. After variables were recoded to represent cancer site
(e.g., GI, gynecologic, skin), as outlined by the NIH (2016), there was no association
between stage and cancer site [χ2 (60, n = 467) = 48.75, p = .85, phi = .32]. Finally, the
pattern of well-being, across the stages, differed for the three subjective present well-
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being categories (thriving, 50.8%; struggling, 39.7%; suffering, 9.5%), χ2 (8, n = 461)
= 28.4, p < .001, phi = .25.
External Validity of Stage of Change Action Criterion
To test the validity of the Stage of Change measure, differences in subjective
well-being scores [42] among individuals in pre-Action versus Action/Maintenance
Stages of Change were evaluated using ANOVA. A significant difference was
observed in present well-being scores between those in pre-Action stages versus
Action/Maintenance (F (1, 1008) = 4.89, p = .03, h2 = .01). Individuals in the preAction stages (M = 6.34, SD = 2.32) reported significantly greater levels of subjective
well-being than individuals in Action or Maintenance (M = 6.01, SD = 2.37).
However, an ANOVA revealed that between-stage differences in future subjective
well-being scores were not significantly different for those in the pre-Action and
Action stages, (F(1, 1010) = .02, p = .88). Finally, a chi-square test revealed an
association between subjective well-being category (thriving, struggling, suffering)
and Stage of Change, χ2 (8, n = 461) = 28.40, p < .001, phi = < .001.
Decisional Balance and Self-efficacy
Exploratory Analyses
Exploratory procedures included PCA with varimax rotations. Sample size (n
= 237) was adequate based on existing literature [46]. Decisions regarding retention of
components were based on parallel analysis and minimum average partial procedures
(MAP), both of which have been found to be accurate methods. Exploratory analyses
were used to determine the number of components, the correlation between
components, and the loadings of items on these components. Items with poor (<.40)
15

and/or complex loadings (>.40) on more than one factor were removed. In later steps,
items with content overlap were removed.
Decisional Balance
Twenty-one decisional balance items were included in the initial exploratory
factor analysis. PCA with varimax rotation on the 21 x 21 matrix of item
intercorrelations was conducted to determine the factor structure of the decisional
balance measure. A total of 6 iterative PCAs were conducted, which reduced the
original pool of 21 items to 16, with 8 items reflecting Pros and 8 items reflecting
Cons. Parallel analysis indicated a two-factor solution. Examination of the item
content revealed that one factor (8 items) clearly reflected the pros of utilizing
psychosocial services and one factor (8 items) clearly reflected the cons of utilizing
psychosocial services. All item loadings were above 0.522. Internal consistency was
excellent for the Pros scale (α = 0.933) and good for the Cons scale (α = 0.809).
Together, the two factors accounted for 56.41% of the total variance (35.66% for Pros
and 20.74% for Cons). The retained items can be viewed in Figure 4.
Decisional Balance – Short Form (DB-SF)
For development of the DB-SF, the 16 decisional balance items from the full
measure were included in the initial exploratory factor analysis. PCA with varimax
rotation on the 16 x 16 matrix of item intercorrelations was conducted to determine the
factor structure of the measure. A total of 3 iterative PCAs was conducted, which
reduced the original pool of 16 items to 8, with 4 items reflecting Pros and 4 items
reflecting Cons. Parallel analysis indicated a two-factor solution, which was retained.
Examination of item content revealed that one factor (4 items) clearly reflected the
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pros of utilizing psychosocial services and one factor (4 items) reflected the cons of
utilizing psychosocial services. All item loadings were above .641. Internal
consistency was good for the Pros scale (α = .874) and acceptable for the Cons scale
(α = .716). Together, the two factors accounted for 61.94% of the total variance
(38.29% for Pros and 23.66% for Cons). The final set of retained items can be viewed
in Figure 5.
Self-efficacy
All nine Self-efficacy items were included in the initial exploratory factor
analysis. PCA with varimax rotation on the 9 x 9 matrix of items intercorrelations was
conducted to determine the factor structure of the measure. Four PCAs were
conducted, which reduced the initial pool of nine items to six. MAP and parallel
analysis supported a single component solution. However, PCA supported a twocomponent solution. Therefore, the two-factor solution was retained. Examination of
the item content revealed that one factor (3 items) clearly reflected the physical
challenges to utilizing psychosocial services (α = .904) and one factor (3 items) clearly
reflected the social and emotional challenges utilizing psychosocial services (α =
.757). Item loadings ranged from .667 to .919. The resulting scale had good internal
consistency (α = .826) and accounted for 75.46% of the total variance. The final set of
retained items can be found in Figure 6.
Confirmatory Analyses
Confirmatory factor analyses were conducted with the structural equation
modeling software, EQS, using the remaining subsample (n = 238) [46]. Maximum
likelihood estimation methods were used for fit indices since item data was ordinal
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[46]. The fit indices calculated were the Satorra-Bentler scaled chi-square, the
comparative fit index (CFI), and the absolute standardized residual statistic (AASR).
CFI values of 0.90 and above are considered to indicate good fit [47]. RMSEA values
between .05 and .08 suggest reasonable error of approximation and values >.10
indicate poor fit [48].
Decisional Balance
The following measurement models were compared for the 16-item Decisional
Balance measure: (1) a null model that supported 16 independent variables and no
latent factors; (2) a single-factor model; (3) a two-factor uncorrelated model; and (4) a
two-factor correlated model. Fit indices for each model are summarized in Table 3.
The two-factor correlated model showed the best fit to the data. Factor loadings
ranged from .464 to .878. Fit indices suggested good model fit, χ2(103) = 349.563, p <
.001, CFI = .928, RMSEA = .075. The correlation between the two scales was r = .147
and rho coefficients were excellent for Pros (ρ = .932) and good for Cons (ρ = .816).
The final items and their loadings in the confirmatory subsample are presented in
Figure 5.
Decisional Balance – Short Form (DB-SF)
The following measurement models were compared for the 8-item Decisional
Balance (SF) measure: (1) a null model that supported 8 independent variables and no
latent factors; (2) a one-factor model; (3) a two-factor uncorrelated model; and (4) a
two-factor correlated model. Fit indices for each model are summarized in Table 3.
The two-factor correlated model showed the best fit to the data. Factor
loadings ranged from .641 to .893. Fit indices suggested good model fit, χ2(19) =
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68.56, p < .001, CFI = .962, RMSEA = .078. The correlation between the two scales
was r = .14 and rho coefficients were good for Pros (ρ = .872) and acceptable for Cons
(ρ = .755). The final items and their loadings in the confirmatory subsample are
presented in Figure 5.
Self-Efficacy
The following measurement models were compared for the Self-efficacy scale:
(1) a null model that supported six independent variables and no latent factors; (2) a
single factor model; (3) an uncorrelated 2-factor model; and (4) a correlated 2-factor
model. Fit indices for each model are summarized in Table 3.
The correlated two-factor model had the best fit. Factor loadings ranged from
.572 to .923 and there was excellent model fit, χ 2(8) = 23.72, p = .003, CFI = .989,
RMSEA = .067. The correlation between the two factors was r = .575. Internal
consistency was good (“social/emotional” α = .757; “physical” α = .904; total α =
.851). Final items and loadings are presented in Figure 2.
External Validation
Decisional Balance by Stages of Change
Multivariate analysis of variance (MANOVA) indicated that individuals at
different Stages of Change differed significantly on Decisional Balance constructs for
the full (F(8,878) = 12.04, p < .001, Wilks’ l = .812; η2 = .10) and short-form (SF)
(F(8,894) = 12.72, p < .001, Wilks’ l = .806; η 2 = .10) measures. Follow-up
ANOVAs indicated significant between-stage differences on the Pros for the full
measure (F(4,449) = 18.39, p < .001, η2 = .14) and for SF; F(4,454) = 19.64, p < .001,
η2 = .15. Post hoc analyses indicated that the Pros were significantly higher for
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individuals in the Action and Maintenance stages than for those in the
Precontemplation stage.
Follow-up ANOVAs indicated significant between-stage differences on the
Cons for full measure (F(4,452) = 5.48, p < .001, η2 = .05) and SF (F(4,456) = 6.7, p <
.001, η2 = .06. Post hoc analyses indicated that the Cons were significantly lower for
individuals in the Action and Maintenance stages than for those in the
Precontemplation stage. Weighted T scores of Pros and Cons at each Stage of Change
are presented in Figures 1 and 2.
Self-efficacy by Stages of Change
Multivariate analysis of variance (MANOVA) indicated that Self-Efficacy was
significantly different across the Stages of Change, (F(8,906) = 6.18, p < .001, Wilks’
l = .899; η2 = .05). Follow-up ANOVAs indicated significant between-stage
differences on the Physical (F(4,456) = 4.31, p < .01, η2 = .04) and Social/Emotional
(F(4,459) = 10.49, p < .001, η2 = .08) factors. Follow-up comparisons showed that
Self-efficacy of individuals in the Precontemplation and Preparation stages was
substantially lower than that of those in the Action and Maintenance stages. Weighted
T- scores of Self-efficacy at each Stage of Change are presented in Figure 4.
External Validation
A series of linear regressions were conducted to evaluate relationships between
subjective well-being (present and future) scores and TTM constructs (Pros, Cons,
Physical Self-Efficacy, and Social/Emotional Self-Efficacy). Greater subjective
present well-being was associated with greater Physical Self-Efficacy (β = .06, p <
.05). Additionally, greater subjective future well-being scores were associated with
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fewer perceived Cons (β = -.11, p <.001). However, no significant relationships
between present well-being and Social/Emotional Self-Efficacy (β = .01, p = .75),
Cons (β = -.01, p = .66), and Pros (β = .05, p = .15) were observed. Finally, results
revealed no significant relationships between future well-being and Pros (β = .03, p =
.31), Physical Self-Efficacy (β = .05, p = .14), and Social/Emotional Self-Efficacy (β =
.05, p = .09).
DISCUSSION
Results supported the validity of the Stages of Change measure and its
relationship with key TTM constructs. Measure development results demonstrated
good construct validity for Decisional Balance and Self-Efficacy in a national sample
of adults diagnosed with cancer. Additionally, both scales demonstrated external
validity in their relationship with Stages of Change. Consequently, the present study
provides evidence of validity for measures that may be used to design and manage
interventions in cancer treatment settings.
Stages of Change for Psychosocial Care
Findings supported the validity of Stages of Change for psychosocial care.
First, the significant association between subjective well-being category (thriving,
struggling, suffering) and Stage of Change for Psychosocial Care was consistent with
previous literature. Based on these, interventions and treatment team members should
consider individuals’ subjective well-being in encouraging psychosocial care. Second,
the significant difference in subjective present well-being between those in the preAction (i.e., Precontemplation, Contemplation, Preparation) and Action stages
(Action, Maintenance) was also consistent with previous literature. Surprisingly,
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however, no significant differences were observed between stage groups for subjective
future well-being or well-being category. One interpretation for this finding may be
that uneven membership in well-being categories (50.8% thriving, 39.7% struggling,
9.5% suffering) limited our ability to find differences between small groups. Notably,
the weekly U.S. Life Evaluation of 3,500 randomly selected adults revealed that
54.9% were thriving, 42.1% were struggling, and 3% were suffering [49]. This
distribution across wellbeing categories in a national sample of well adults was
remarkably similar to the distribution found in this sample of cancer patients. This
suggests that even when faced with a life-threatening illness, subjective life
evaluations remain comparable. Thus, overall findings support the future use of Stage
of Change for psychosocial care.
Decisional Balance
The present study supported a two-factor correlated model for the Decisional
Balance scale, with one factor reflecting the Pros and the other the Cons of engaging
in psychosocial care. This was consistent with previous studies, in which a two-factor
Decisional Balance model was observed across health risk behaviors [48]. Further, the
present findings converged with existing literature, with regard to the Cons
outweighing the Pros in Precontemplation and an increase in Pros with progress to the
Action and Maintenance Stages of Change [38]. Thus, Decisional Balance emerged as
a critical construct in readiness to engage in psychosocial care.
In comparing Decisional Balance for psychosocial care with other problem
areas, one difference emerged. There was an increase in perceived Cons between the
Precontemplation and Contemplation stage groups, as well as between the Preparation
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and Action stage groups. One interpretation of this trend may be that ambivalence
occurs during Preparation and Action stages, as opposed to Precontemplation.
Nonetheless, the general trend was similar to the trend observed in other areas of
behavior change, such that the Cons were more salient than Pros in Precontemplation,
whereas Pros were more salient than Cons in Maintenance. Although replication and
longitudinal follow-up are warranted, the present study suggests that tailored
interventions should focus on feedback to address Cons during the Contemplation and
Action stages, in order to maintain forward stage progress. For example, clinicians
could address patient concerns regarding continuing psychosocial care throughout the
Action stage. Given the common patient concern regarding psychologists sharing
treatment information with the rest of the treatment team, best practices should be
used in communicating psychosocial treatment information [49].
Findings were mixed with regard to the relationship between subjective wellbeing and perceived Pros and Cons. First, there was no relationship between Pros and
present or future subjective well-being. Second, no relationship was observed between
Cons and present subjective well-being. However, individuals with greater future
subjective well-being perceived fewer Cons of engaging in psychosocial care. Thus,
addressing perceived Cons of psychosocial care may be helpful in modifying
subjective future well-being. However, given these cross-sectional findings, those with
greater future well-being scores may be perceiving fewer cons of psychosocial care.
Self-Efficacy
This research supported a two-factor correlated model for Self-Efficacy. This
finding diverged from some previous research on Self-Efficacy across other health
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behavior change, in which a single-factor scale was supported. Nonetheless, SelfEfficacy was greater for individuals in the Action and Maintenance stages, compared
with those in the pre-Action stages – a finding observed in other areas of behavior
change. The present finding is comparable to situational temptations subscales
(Positive Social, Negative Affect, and Habit Strength) observed for smoking [40] and
high-fat diet [50]. One implication of the two-factor Self-Efficacy model is the strong
physical component to having cancer. As such, experiencing pain, physical
discomfort, and fatigue collectively reflect a unique component to Self-Efficacy. This
finding sheds light on the low engagement rates among cancer patients, as they face
unique challenges due to physical demands of their diagnoses and treatments.
Accordingly, tailored interventions and treatment teams may consider and incorporate
physical aspects of patients’ cancer experiences in psychosocial care engagement.
Notably, these findings support the use of integrative care approaches to cancer
treatment – ones that incorporate physical therapy, rehabilitation, nutrition services,
and mental health care [53-56].
Validation analyses further supported the developed Self-Efficacy measure.
Self-Efficacy was significantly different across Stages of Change, demonstrating its
utility in facilitating readiness to change. More importantly, Self-Efficacy was
significantly lower in the pre-Action stages, compared with the Action stages,
validating its role in acceptance of psychosocial care. The relationship between SelfEfficacy and present well-being provided further external validation for this measure,
as those with greater confidence for engaging in psychosocial care across a range of
challenging situations had greater subjective present well-being. These results indicate
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that Self-Efficacy may be an essential component for feedback in an intervention or
feedback session aimed at reducing reluctance or ambivalence to meet with a mental
health provide or to attend a support group.
Limitations and Future Directions
This study has several limitations. First, 47.8% and 22.1% of the survey
sample was in Precontemplation and Contemplation, respectively. Although sample
sizes were adequate for internal validation analyses – and scores were weighted by
sample size for external validation analyses, it is likely that the smaller Preparation
(8.1%), Action (8.6%), and Maintenance (13.5%) sample sizes limited the power for
comparisons with other stage groups. Future research evaluating findings in larger
samples including Preparation, Action, and Maintenance stages is warranted. Second,
findings are based on cross-sectional comparisons of individuals in each Stage of
Change. Although cross-sectional findings provide insight into factors that drive
change, they do not warrant longitudinal implications. Third, findings are based on a
sample that is mainly White and non-Hispanic. Furthermore, the qualitative interview
sample (n = 12) consisted exclusively of White participants. Given the differences in
cancer outcomes and mental health stigma among non-White populations [56],
additional research examining the validity of these measures in non-White populations
is warranted. Additionally, repeating the qualitative interviews with a more diverse
sample, from several different hospitals would be useful for further validation. Fourth,
the survey sample consisted of individuals who were enrolled in a health panel and
therefore had interest in online survey research participation, potentially introducing
sample bias. Finally, although the sample was diverse with regard to cancer site and
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cancer treatment type, cancer staging data was not available. Given strong crosscancer stage differences, with regard to physical and psychological functioning (e.g.,
lower physical functioning in Stage IV cancer, compared with Stage I), future research
that investigates cancer staging data is recommended.
Despite its limitations, the study has numerous strengths and can inform future
investigations. Notably, this study developed and validated three key TTM constructs
– Stages of Change, Decisional Balance, and Self-Efficacy for Psychosocial Care in a
large, national sample of cancer patients. These measures can be used in various ways.
First, researchers may evaluate the impact of readiness to engage in psychosocial care
on both, psychological and physiological treatment outcomes, including cancer
survival rates. Second, cancer treatment teams may use this data to inform intervention
strategies. For instance, clinicians may use psychoeducation and motivational
interviewing in order to address ambivalence and thereby foster forward stage
progress. Finally, the study findings support patient distress screenings in order to
increase psychosocial care referrals and consequently, increase engagement in care. In
sum, these findings may be used in intervention development and implementation in
order to design treatments that are tailored to individuals’ readiness to accept
psychosocial care as a component of their cancer treatment plans.
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Table 1.
Demographic Characteristics.
Variable
Sex
Female
Male
Other
Race/Ethnicity
Native American
Asian/Pacific Islander
Black
Hispanic/Latino
Middle Eastern
Multiracial
Other
White
Marital Status
Married
Divorced
Living with partner
Not married
Separated
Widowed
Education
<High school
High school diploma
Some college
Trade/vocational school
Associate degree
Bachelor's degree
Master's degree
Professional/doctorate degree
Stage of Change
Precontemplation
Contemplation
Preparation
Action
Maintenance

Participants
% (n)
54.6% (n=255)
44.3% (n=207)
1.1% (n=5)
1.9% (n=9)
1.9% (n=9)
4.1% (n=19)
4.9% (n=23)
0.4% (n=2)
6.9% (n=32)
0.9% (n=4)
79% (n=368)
54.3% (n=253)
12.7% (n=59)
11.2% (n=52)
17% (n=79)
1.3% (n=6)
3.6% (n=17)
2.5% (n=12)
14.8% (n=69)
19.3% (n=90)
6.9% (n=32)
12% (n=56)
25.7% (n=120)
12.6% (n=59)
6.2% (n=29)
47.8% (n=223)
22.1% (n=103)
8.1% (n=38)
8.6% (n=40)
13.5% (n=63)
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Table 2.
Medical Characteristics.
Variable

Participants

Cancer Site
Breast
Digestive/Gastrointestinal
Endocrine/Neuroendocrine
Eye
Genitourinary
Gynecologic
Head & Neck
Hematologic/Blood
Musculoskeletal
Neurologic
Respiratory/Thoracic
Skin
Unknown Primary
Metastasized
Other
Soft Tissue
Treatment location
Homeopath
Major cancer center
Not receiving treatment
Outpatient office
General hospital
Community hospital
VA hospital
Treatment type (not mutually exclusive)
Blood Product Donation
Chemotherapy
Homeopathy
Hyperthermia
Immunotherapy
Photodynamic therapy
Radiation
Stem Cell Transplant
Surgery
Targeted therapy

% (n)
16.8 (n=79)
8.7 (n=41)
4.9 (n=23)
0.4 (n=2)
12.4 (n=58)
8.5 (n=40)
3.4 (n=16)
6.6 (n=31)
0.6 (n=3)
1.3 (n=6)
1.5 (n=7)
9 (n=42)
0.2 (n=1)
23.5 (n=110)
1.7 (n=8)
0.4 (n=2)
1.5% (n=7)
19.4% (n=92)
7.8% (n=37)
33.5% (n=159)
37.9% (n=180)
9.7% (n=46)
5.7% (n=27)
7.8% (n=37)
43.4% (n=206)
4.4% (n=21)
4.4% (n=21)
6.1% (n=29)
1.3% (n=6)
38.1% (n=181)
2.7% (n=13)
52.4% (n=249)
11.6% (n=55)
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Table 3.
Fit Indices for Evaluated Decisional Balance and Self-Efficacy Confirmatory Models
χ 2 (df)

CFI

RMSEA (CI)

3546.08 (120)
1126.87 (104)*
356.74 (104)*
349.56 (103)*

-.701
.926
.928

-.152 (.144, .160)
.076 (.067, .084)
.075 (.066, .084)

1342.98 (28)
449.39 (20)*
224.56 (20)*
68.56 (19)*

-.673
.891
.962

-.223 (.205, .240)
.163 (.143, .311)
.078 (.058, .097)

1400.959 (15)
239.147 (9)*
146.612 (9)*
23.72 (8)**

-.834
.901
.989

-.242 (.215, .268)
.187 (.16, .213)
.067 (.037, .099)

Decisional Balance
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Model 1: null model
Model 2: one-factor model
Model 3: uncorrelated two-factor model
Model 4: correlated two-factor model
Decisional Balance-Short Form
Model 1: null model
Model 2: one-factor model
Model 3: uncorrelated two-factor model
Model 4: correlated two-factor model
Self-Efficacy
Model 1: null model
Model 2: one-factor model
Model 3: uncorrelated two-factor model
Model 4: correlated two-factor model

Note. N = 238; χ 2 = chi square; df = degrees of freedom; CFI = comparative fit index; RMSEA = root mean square error of
approximation; CI = confidence interval; *p < .001; **p < .01.

Table 4.
Summary of Raw Scores on Pros, Cons, and Self-Efficacy by Stage

Pros

38

Stage
Precontemplation
Contemplation
Preparation
Action
Maintenance

N
219
101
37
40
60

Mean (SF)
24.2 (11.86)
29.16 (14.51)
29.65 (14.66)
29.63 (14.95)
31.87 (15.95)

Cons
SD (SF)
7.57 (4.00)
7.36 (3.80)
7.97 (4.28)
7.29 (3.56)
7.42 (3.71)

Mean (SF)
20.79 (8.93)
23.19 (10.75)
19.51 (8.70)
22.05 (9.87)
18.37 (7.84)

Self-Efficacy
SD (SF)
5.97 (3.60)
7.65 (4.21)
7.79 (4.33)
6.66 (3.76)
8.03 (4.06)

Mean
17.08
19.32
20.19
18.97
20.61

SD
5.54
5.3
4.7
4.27
4.75

Note. Mean = average sum score; higher scores indicate more importance for Pros and Cons and more confidence for Self-Efficacy;
SD = standard deviation; scores in parentheses indicate those from the Decisional Balance Short – Form (SF) measure

Table 5.
2 x 2 Contingency Table for Chi-Square Test Reporting the Association between
Subjective Well-Being Category and Stage of Change

Stage

Subjective Well-Being Category
Struggling
Thriving /Suffering
Pre81.2%
74.9%
Action
(190)
(170)
18.8%
25.1%
AM
(44)
(57)

Note. Pre-Action = Precontemplation, Contemplation, or Preparation Stages; AM =
Action or Maintenance Stages.
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Figure 1.
Stage of Change by Decisional Balance.

54
53
52
51
50

T-Score

49
48
47
46
Pros

45

Cons

44
43
PC (n=223)

C (n=103)

PR (n=38)
Stage of Change

A (n=40)

M (n=63)

Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M =
Maintenance
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Figure 2.
Stage of Change by Decisional Balance – Short Form (SF).

57
56
55
54
53

T-Score

52
51
50
49
48
47
46
Pros

45

Cons

44
43
PC (n=223)

C (n=103)

PR (n=38)

A (n=40)

M (n=63)

Stage of Change

Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M =
Maintenance
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Figure 3.
Stage of Change by Self-efficacy.

57
56
55
54
53

T-Score

52
51
50
49
48
47
Physical

46

Social/Emoti
onal

45
44
43
PC (n=223)

C (n=103)

PR (n=38)
Stage of Change

A (n=40)

M (n=63)

Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M =
Maintenance; “physical” represents the physical challenges to engaging in
psychosocial care and “social/emotional” represents the social and emotional
challenges to engaging in psychosocial care
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Figure 4.
Decisional Balance Structural Model (N=238)
I could improve the quality of my
life

It would be embarrassing if my friends or
family found out that I am seeing a
psychologist or counselor

I could identify any problems
that I am experiencing and set
goals for addressing them

Seeing a therapist is unlikely to
help me cope with my cancer
diagnosis and treatment

I can talk to someone who can be
helpful about the issues I am
experiencing

43

Having a therapist or counselor
on my treatment team can
improve my health
Therapy can help me deal with
issues related to my health
Psychosocial care can help me
cope with stress related to my
diagnosis and treatment
Receiving psychosocial care may
improve my cancer prognosis
Psychosocial care can help me
deal with interpersonal issues
related to my diagnosis

.71

r = .15

.56

.66

.46

.78
.83

.67
Pros
α = 0.93

Cons

α = 0.81

.52

.86

.68

.89

.75

.71
.86

.65
.46

It is uncomfortable to talk about
my problems with a stranger
My cancer treatments can leave
me too fatigued for
psychotherapy
Seeking help is a sign of
weakness
I would be uncomfortable if my personal
information was shared with other
members of my treatment team

Time in psychotherapy can take
away from the things I’d rather
do
I feel that I can cope with the
stress related to cancer without
therapy

Figure 5.
Decisional Balance (Short Form) Structural Model (N=238)
It would be embarrassing if
my friends or family found out
that I am seeing a psychologist
or counselor

I could improve the quality of
my life

44

r =.14

.67

.55

Psychosocial care can help me
cope with stress related to my
diagnosis and treatment

Seeking help is a sign of
weakness

.69

.89
Pros
α = .87
Receiving psychosocial care
may improve my cancer
prognosis

Psychosocial care can help me
deal with interpersonal issues
related to my diagnosis

Cons

α = .75

.72

.79

.87

.60

I would be uncomfortable if
my personal information was
shared with other member of
my treatment team

Time in psychotherapy can
take away from the things I’d
rather do

Figure 6.
Self-Efficacy Structural Model

You need to share
feelings about your
diagnosis and
treatment

How confident are you that you can
engage in psychosocial are when…?

You are feeling
fatigued

r = .58

.88

.86

45
You have to
follow-up in
therapy or support
group meetings

.84

.67
Family members or
friends do not see
the value in
psychosocial care

Social

Physical

α = 0.76

α = 0.90

.92

You are in pain

.89
You are in physical
discomfort
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Abstract
BACKGROUND. Cancer patients frequently experience considerable distress during
diagnosis and treatment. The aims of this study were to describe the development and
utilization of a behavioral health program for cancer patients, at a small community
hospital, as well as to provide preliminary results on program efficacy. METHODS.
This program was developed collaboratively by individuals from a university-based
clinical psychology doctoral program and a community hospital. The behavioral health
program was comprised of a licensed, PhD-level clinical psychologist and seven
clinical psychology doctoral students. Patients were typically referred by their
oncologists or nurses. Distress, depression, and anxiety were evaluated for a small
subsample of participants. RESULTS. From the time the program was initiated, 238
patients between ages 18 and 95 (M = 66.4) were evaluated over a three-year period.
The majority of patients (77.8%) were offered psychosocial care. Although 49.8%
declined treatment, 23.6% engaged in one session and 26.6% engaged in two or more.
Patients who were referred through the STAR Program® were more likely to engage
in psychosocial care than those who found out about behavioral health in other ways.
CONCLUSIONS. First, distress tracking may be improved if nurses, oncologists, and
behavioral health providers administer measures. Second, partnerships between
clinical psychology doctoral programs and hospitals may be mutually beneficial.
Third, hospitals offering cancer treatment may benefit from obtaining STAR®
certification, in order to generate referrals for comprehensive cancer care. These
efforts can serve as a model for other hospitals seeking to integrate behavioral health
into routine cancer treatment.
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Given improvements in early detection, diagnosis, and treatment, individuals
with cancer are living longer. Often times, their diagnosis may be managed as a
chronic illness (McCorkle et al., 2011). However, although providers may be
prolonging lives, insufficient attention is being paid to quality of lives. In 2005, The
Institute of Medicine (IOM)’s report, From Cancer Patient to Cancer Survivor: Lost
in Transition, discussed a cancer care continuum, ranging from diagnosis and
treatment, to survivorship. This report, along with changing U.S. health care delivery
systems, underscores the importance of better integrated models of care. Such models
include partnerships between oncologists and providers from other disciplines,
including psychology, social work, and primary care. More importantly, given that
severe and acute distress often begins at the time of cancer diagnosis, these
partnerships should last throughout the cancer care continuum in order provide care
that can improve clinical outcomes and enhance quality of life simultaneously
(Andersen et al., 2009). Notably, oncologists and nurses are encouraged to have
discussions with patients regarding the psychosocial effects of cancer, in part to
connect patients to psychosocial services (Forsythe et al., 2013). To illustrate the
distinct and unique role of such partnerships, Silver & Baima (2013) defined cancer
“pre-habilitation” as a process, on a continuum of care, that occurs between the time
of cancer diagnosis and the beginning of acute treatment, including physical and
psychological assessments.
The changing U.S. healthcare landscape places an urgent emphasis on
improving the quality of patient care and on reducing overall costs, particularly within
hospitals. A recent systematic review of 78 studies revealed that collaborative care
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models improved mental and physical outcomes for individuals with mental disorders
across a wide variety of care settings, supporting care integration (Woltmann et al.,
2012). Similarly, a review of psychosocial interventions for cancer revealed that the
biomedical model of disease does not take into account all of the complex factors
involved in cancer, underscoring the need for a broader, more integrative framework
for cancer care that integrates psychosocial factors (Shapiro et al., 2001). Notably,
recent models have converged on the use of multimodal, multidisciplinary
interventions to decrease cancer-related morbidity, increase survival rates, improve
physical and psychological health outcomes, decrease hospital readmissions, and
reduce healthcare costs (e.g., Mehnert & Koch, 2008; Purushotham, et al., 2013;
Stanton, Luecken, MacKinnon, & Thompson, 2013). Findings from a recent study of
1,083 women with breast cancer generated recommendations for patient education,
screening for psychosocial distress, and tailoring psychosocial interventions for older
women (Mehnert & Koch, 2008). Unfortunately, despite evidence that up to 35% of
patients with cancer experience significant distress, only five percent obtain
psychological help (National Comprehensive Cancer Network, 2016). Access to
effective psychosocial care is often limited by lack of systematic approaches to
assessment, scarcity of psychosocial services, and patient reluctance to accept
treatment, mainly due to perceived stigma (Zabora et al., 2001). Nonetheless, the
literature has evolved to encourage broader and better integrated models of care, rather
than treating cancer from a solely biomedical model.
Given the limitations of the biomedical model, research supports that
multidisciplinary collaborative care teams are more likely to deliver favorable cancer
50

treatment outcomes. Notably, a randomized trial of psychosocial support groups
revealed that the use of multidisciplinary collaborations enhanced enrollment rates in
psychosocial interventions (Goodwin et al., 2000). Such improvements have often
been attributed to having cancer treatment providers (e.g., oncologists, nurses)
introduce and recommend behavioral health treatment, thereby increasing
engagement. However, due to insufficient behavioral health providers in oncology
settings, nurses and oncologists are often expected to screen for patient distress and to
provide therapeutic services (Fallowfield, Ratcliffe, Jenkins, & Saul, 2001).
Problematically, Sollner et al. (2001) found that oncologist recommendations for
counseling did not correlate with patient distress, implying that oncologists’ ability to
identify patients in distress is generally insufficient. Additionally, a recent study of
448 oncologists revealed that 38% of their patients experienced psychological distress
requiring intervention, but only half of those oncologists had any mental health
services affiliated with their practices. Additionally, only 47% made a referral for
psychosocial services (Muriel et al., 2015). These data suggests that multidisciplinary
teams, representing professionals with different areas of expertise (e.g., nursing,
oncology, psychology) may be more likely to deliver effective care and to enhance
treatment outcomes. However, providing psychosocial care to cancer patients comes
with numerous barriers, including the need for systematic approach to identifying
patients with unmet psychosocial needs, as well as provider, patient, financial, and
organizational challenges (Fann & Sharpe, 2012).
Survivorship Training and Rehabilitation (STAR) Program ®
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STAR® is a free access, evidence-based program that provides nutrition
counseling, physical rehabilitation, caregiver support, monitoring tools, and behavioral
health services for cancer patients (Kirschner et al., 2013; Silver et al., 2013; Silver &
Baima, 2013; Silver, Baima, Mayer, 2013; Silver & Gilchrist, 2011; Silver & Mayer,
2007; Silver, 2007; 2010; 2011; 2013; 2014; 2014; Silver et al., 2015a,b). The
program aims to address a wide array of cancer-related physical and psychological
impairments, all of which potentially interfere with treatment recommendations and
coping. As of November 2016, 549 hospitals or cancer centers possess STAR®
certification, nationwide. The main benefits of possessing STAR Program®
certification are: 1) improved patient outcomes, by way of intervening on quality of
life with evidence-based clinical protocols; 2) increased access to care; 3) improved
clinician knowledge, while improving delivery of care; 4) increased patient referrals,
which often generate a self-sustaining service and decrease the economic impact of
cancer on patients, caregivers, and the healthcare system; and 5) enhanced community
education by supporting local and regional awareness initiatives (STAR®, 2015).
Purpose of Current Study
As the literature supporting the efficacy of biobehavioral cancer care
continues to grow (e.g., Lutgendorf & Anderson, 2015) a dearth of reporting on
psychosocial cancer care programs prevails. Notably, a recent study revealed the
scarcity of studies on the intersection of cancer and mental health and suggested the
need to bridge the gap between these two disciplines, in order to prevent and treat
mental health problems in cancer patients (Purushotham et al., 2013). Collectively,
research has identified: 1) a gap between the need for and delivery of services; 2) that
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dual screening for psychological distress and physical impairment is critical for
optimal outcomes; and 3) integrated rehabilitative services are cost-effective.
Accordingly, the current study describes the development, preliminary evaluation, and
utilization of a behavioral health program integrated into routine cancer care at a
STAR Program® - certified hospital.
METHODS
Setting and Program Description
The study took place at an independent, non-profit acute care hospital serving
[area masked for anonymous review]. Prior to the beginning of data collection, the
program was collaboratively designed by hospital administrators, clinicians, and staff,
as well as faculty and two graduate students from a clinical psychology doctoral
program at a northeastern, public research university. The goals of this program were
to: 1) increase access to behavioral health services to cancer patients; and 2) provide
students with a one-year, formally supervised clinical training experience.
In August 2013, one emeritus faculty member [masked for anonymous review]
and two doctoral Psychology students [masked for anonymous review] were recruited
to implement behavioral health services for patients receiving cancer treatment on an
outpatient basis. The faculty member served as the clinical supervisor for the two
students and provided weekly group and individual supervision for all cases. All three
providers documented clinical encounters. Upon completion of this training
experience (August 2014), three new doctoral Psychology students replaced the first
two students, although one of the students [masked for anonymous review] remained
on the team as a peer supervisor from 2014 to 2015.
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During Year 2 (2014-2015) of this program, [masked for anonymous review]
launched a weekly, three-hour didactic seminar co-led by a Clinical Assistant
Professor of Psychiatry in the Behavioral Medicine Track at [masked for anonymous
review] and the peer supervisor [masked for anonymous review] to supplement the
training experience, formally named the “Health Practicum”. The purpose of the
didactic portion of this practicum was to: 1) provide additional supervision; 2) hold
formal trainings on health psychology; and 3) discuss the application of CognitiveBehavioral Therapy (CBT) and Acceptance and Commitment Therapy to cancer
patients and other clinical populations. Upon completion of this training experience in
August 2015, two new doctoral students joined the behavioral health team at the
hospital for Year 3 (2015-2016) of the program. This program continues to be
available to all patients and caregivers at [masked for anonymous review] and the
“Health Practicum” continues to run.
All behavioral health providers completed the STAR Program® Certification
course. The course is a 10-module training, based on recent evidence on best practices
with regard to cancer treatment and rehabilitation. The modules covered a vast array
of information, including an overview of cancer rehabilitation, an overview of cancer
biology and available treatments, common impairments related to cancer, and best
practices for selecting assessment tools. Upon completion of the course, participants
took the STAR® Certification Test, an online examination in order to receive STAR®
Clinician Certification.
Data Collection
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All procedures were in accordance with the Institutional Review Boards of
[masked for anonymous review] and [masked for anonymous review]. The period of
data collection was from the initiation of behavioral health services (August 2013) to
June 30, 2016. Nursing staff administered the National Cancer Care Network (NCCN)
distress thermometer (NCCN, 2016) to patients and compiled the documentation for
behavioral health staff. The purpose of NCCN administration was to: 1) screen for
distress; 2) provide preliminary data for behavioral health staff; and 3) prioritize
patient assignments (i.e., in the event of understaffing, patients with a higher distress
scores would be seen first).
Measures
Demographics. Patients who accepted psychosocial treatment provided their gender,
age, race/ethnicity, marital status, and employment status during the intake. A
retrospective chart review was conducted to obtain this information from individuals
who only attended support groups or those who were referred, but declined
psychosocial care. For all patients, medical information was obtained, including
cancer site, cancer stage, and cancer treatment type.
Cancer Staging. The TNM system is one of the most widely used cancer staging
systems. It is based on the size and extent of the primary tumor (T), the degree of
spreading to nearby lymph nodes (N), and the presence or absence of metastasis (M).
A number is added to each letter to indicate the size or extent of primary tumor and
degree of cancer proliferation. Primary Tumor (T) can be noted as TX (primary tumor
cannot be evaluated), T0 (no evidence of primary tumor), Tis: Carcinoma in situ (CIS;
abnormal cells are present, but have not spread to neighboring tissue and may become
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cancerous), T1, T2, T3, T4 (size and/or extent of the primary tumor). Regional Lymph
Nodes (N) may be noted as NX: Regional lymph nodes cannot be evaluated, N0: No
regional lymph node involvement; N1, N2, N3: Degree of regional lymph node
involvement. Metastasis (M) may be noted as MX: distant metastasis cannot be
evaluated; M0: no distant metastasis; M1: distant metastasis is present (Greene &
Sobin, 2002).
Depression. The Beck Depression Inventory (BDI-II) is a 21-item, self-report rating
inventory that measures characteristic attitudes and symptoms of depression (Beck,
Ward, Mendelson, Mock, & Erbaugh, 1961), such as hopelessness and loss of interest.
Higher scores on the BDI reflect more depressive symptomatology. Internal
consistency for the BDI ranges from .73 to .92, with a mean of .86 (Beck, Steer, &
Garbin, 1988). The BDI demonstrates high internal consistency, with alpha
coefficients of .86 and .81 for psychiatric and non-psychiatric populations,
respectively (Beck et al., 1988). The BDI-II has been used in a variety of medical and
healthcare settings, including primary care (Arnau, Meagher, Norris, & Bramson,
2001; Beck, Guth, Steer, & Ball, 1997), coronary heart disease (Berkman et al., 2006),
and breast cancer (Love, Grabsch, Clarke, & Kissane, 2004).
Anxiety. The Beck Anxiety Inventory (BAI) is a 21-item self-report inventory for
measuring the severity of anxiety, with higher scores reflecting higher anxious
symptomatology. It has a high internal consistency (α- .92) and test-retest reliability
over 1 week r(81) = .75. The BAI discriminates anxious diagnostic groups (panic
disorder, generalized anxiety disorder, etc.) from non-anxious diagnostic groups
(major depression, dysthymic disorder, etc.). The BAI has been used in various
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medical and health settings, including bone marrow transplantation (Manne et al.,
2001), coronary artery bypass surgery (Hartford, Wong, & Zakaria, 2002), and chronic
pulmonary disease (Cully et al., 2006).
Distress. The National Comprehensive Cancer Network (NCCN) Distress
Thermometer for Cancer Patients is a self-report measure that has been used to
identify patients with elevated psychological distress, in various domains, including
financial, emotional, and physical, with the patients noting subjective levels of
distress, ranging from 0 (no distress) to 10 (extreme distress) (Goebel & Mehdorn,
2011; Holland & Bultz, 2007; Jacobsen et al., 2005; Patel, Sharpe, Thewes, Bell, &
Clarke, 2011).
Analytic Plan
All data analyses were conducted using the Statistical Package for the Social
Sciences, Version 24.0 (SPSS 24.0). First, a series of chi-square tests of independence
were conducted to determine associations between demographic variables and medical
characteristics. Second, chi-square tests were run to determine relationships between
demographic and medical characteristics, and behavioral health program utilization,
respectively. Finally, repeated-measures within-subjects ANOVAs, with Bonferroni
corrections, were run to examine changes in depression and/or anxiety between the
first and second, as well as first and final sessions with behavioral health providers.
Alpha was established at the .05 level.
RESULTS
Demographic and Medical Characteristics
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From August 2013 to June 2016, a total of 306 patients received cancer
treatment at the Infusion Therapy Department of the hospital. Behavioral health
program data was available on 238 patients, representing 77.8% of the total cancer
patient population. The participants ranged in age from 18 to 95 (Mage = 66.4, SD =
12.9).
The majority of the participants (54.2%) identified as female, 45.4% identified
as male, and 0.4% identified as “other”. The majority (85.7%) of participants
identified as White, 11.8% identified as Multiracial/ethnic or other, and the remainder
identified as either Black (.8%), Native American (.4%), Asian (.4%), Hispanic (.4%),
or Middle Eastern (.4%). The majority (59.2%) of participants were married.
Additional information regarding patient demographics may be found in Table 1.
In addition to sociodemographic information, medical information was
collected. The most common cancer diagnoses were breast (18.1%) and lung (10.1%).
Further, 19.1% of the sample reported multiple cancer diagnoses, as a result of
metastasis. Given that 29 different cancer diagnoses were prevalent in the sample,
variables were recoded such that diagnoses were organized according to organ
system/site (e.g., gastrointestinal, gynecologic, skin), as presented by the National
Cancer Institute (2016). This revealed that the most common cancer sites were breast
(20.4%) and gastrointestinal (16.6%). From the date of program initiation to June 30,
2016, 17 patients (7.14%) who were offered behavioral health treatment passed away.
Additional information regarding the sample’s medical characteristics may be found in
Table 2.
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Chemotherapy was the most common form of cancer treatment (53.4%),
followed by receiving two or three forms of treatment (18.4%), surgery (6.3%), and
radiation (4.2%). Other treatments included immunotherapy (.4%), targeted therapy
(.4%), and homeopathy (.4%). Additional information regarding the participants’
cancer treatment may be found in Table 2.
Treatment Providers
Three years of data revealed that of the 125 patients seen by the behavioral
health providers, the supervisor and PhD-level licensed psychologist met with the
majority (34.3%, n = 43) of patients. During the first year of the behavioral health
program (2013-2014 academic year), two doctoral Psychology students saw 32.8% (n
= 41) of patients, combined. During the 2014-2015 academic year, two second-year
and one fourth-year Psychology student saw 26.4% of patients (n = 33). Two students
joined the behavioral health staff during the 2015-2016 academic year and saw 8
patients, combined (6.4%).
Evaluation
Well-being
Baseline well-being was assessed using the NCCN, BDI, and BAI. The NCCN
was administered to a subsample (n = 86) of patients. A score of “3” (minimal to mild
distress) was the most frequently reported (18.6%), followed by “7” (moderate
distress; 15.1%). Mean score was 4.36 (SD = 2.63). The BDI was administered to a
subsample (n = 55) of patients. The mean baseline score was 13.96 (mild depression;
SD = 13.96, range = 0-43). The BAI was administered to a subsample (n = 46) of
patients. The mean baseline score was 12.67 (mild anxiety; SD = 9.42, range = 0-39).
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Program Efficacy
Change in depression and anxiety scores between patients’ first and last
sessions was calculated (see Figure 2). For a small subset of patients (n = 17) for
which follow-up depression scores were available, results revealed that the behavioral
health program had a statistically significant effect on depression scores between the
patients’ first (M = 15.29, SD = 6.84) and last (M = 10.47, SD = 6.02) session, F(1,16)
= 8.5, p = .01, h2 = .35. However, for the small subset of patients (n = 14) for which
follow-up anxiety scores were available, change in anxiety between the first (M =
14.29, SD = 10.67) and last (M = 8.86, SD = 6.65) session was not significant, F(1, 14)
= 2.95, p = .11, h2 = .19. To further evaluate potential treatment gains, change in
depression and anxiety scores between patients’ first and second sessions was
calculated. Results revealed that the behavioral health program had a statistically
significant effect on depression scores, F(1,15) = 4.98, p < .05, h2 = .25, between
sessions 1 (M = 15.94, SD = 1.63) and 2 (M = 12.94, SD = 1.5). However, results
revealed that the program’s effects on anxiety scores were not statistically significant,
F (1,14) = .35, p = .57, h2 = .03, between sessions 1 (M = 14.29, SD = 2.85) and 2 (M
= 12.14, SD = 2.06).
Program Utilization
Of the 238 participants, the majority (68.2%) were referred to STAR® for
behavioral health services. The range of time between STAR® referral and initial visit
was zero to 730 days (M = 82.82, SD = 160.53). With regard to overall behavioral
health service utilization, 49.8% did not initiate treatment or declined to meet with
behavioral health staff, 23.6% attended one visit, and 26.6% engaged in two or more
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sessions. The average number of sessions was 2.77 (SD = 8.31, range = 0-96). Chi
square analyses revealed that those who received a STAR® referral were more likely
to engage in treatment, compared with those who found out about behavioral health
services in other ways (e.g., directly approached by behavioral health provider), χ 2 (6)
= 13.68, p = .03. However, the majority (51.9%) of patients who received a referral
did not engage in treatment, 20.8% attended one session, and 27.3% engaged in two or
more. Of the 83 who did not receive a referral, but were offered psychosocial care by
an oncologist, nurse, or behavioral health provider, 45.8% did not engage, 28.9%
attended one session, and 25.3% attended two or more. Finally, the majority of
participants engaged in individual psychosocial care only (50.2%), while five patients
engaged in support groups only (2.1%), and only 2 patients (0.84%) engaged in both,
individual and group care. The average number of group sessions attended was .06
(SD = .43, range = 0-4).
Demographic Characteristics and Program Utilization
A series of chi square tests of independence explored relationships between
demographic variables and behavioral health program utilization. A chi-square test did
not support an association between gender and treatment acceptance, χ2 (2, n = 237) =
4.63, p = .10 or between race/ethnicity and treatment acceptance, χ2 (2, n = 237) =
5.20, p = .07. However, there was an association between being married and accepting
treatment, χ2 (2, n = 237) = 7.92, p < .001; phi = .55, p < .001 and engaging in at least
two psychosocial visits, χ2 (2, n = 237) = 3.66, p < .001; phi = .63, <.001. There was
also an association between being employed and accepting treatment, χ2 (11, n = 237)
= 52.98, p < .001; phi = .473, p < .001 and engaging in at least two visits, χ2 (22, n =
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237) = 59.99, p < .001; phi = .503, p < .001. Finally, there was an association between
being in a younger age group and accepting treatment (compared to those in an older
age group), χ2 (6, n = 237) = 14.84, p = .02; phi = .26, p = .02. There was also an
association between being in a younger age group and engaging in at least two
psychosocial visits, χ2 (3, n = 237) = 10.34, p = .02; phi = .22, p = .01.
Clinical Characteristics and Program Utilization
A series of chi square tests of independence revealed relationships between
clinical characteristics and behavioral health utilization. No relationship between
cancer organ system site and treatment acceptance was observed, χ2 (22, n = 237) =
28.96, p = .15. However, a relationship between cancer diagnosis and treatment
acceptance was observed, χ2 (33, n = 237) = 53.55, p = .01, such that being diagnosed
with leukemia, lymphoma, multiple myeloma, lung, pancreatic, and gastric cancer was
associated with accepting treatment, compared with those diagnosed with cancers with
higher survival rates (e.g., breast; NIH, 2016). Further, there was an association
between cancer diagnosis and engagement in at least two behavioral health
encounters, χ2 (66, n = 237) = 87.79, p = .04. The association between treatment
acceptance and cancer stage was not significant, χ2 (8, n = 237) = 13.87, p = .09. Chi
square tests revealed between receiving chemotherapy and to accepting treatment,
compared with those who were receiving multiple cancer treatments, χ2 (10, n = 237)
= 24.50, p < .01. The association between engaging in at least two sessions and
receiving only one treatment was also significant, χ2 (20, n = 237) = 37.77, p < .01.
Baseline Well-Being and Program Utilization
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Chi square tests did not support an association between baseline anxiety
category (e.g., minimal, mild, severe) and treatment acceptance, χ2 (6, n = 237) = 6.84,
p = .34 or between baseline depression category (e.g., minimal, mild, severe) and
treatment acceptance, χ2 (6, n = 237) = 5.53, p = .48. Further, the association between
treatment acceptance and distress level was not significant, χ2 (20, n = 237) = 17.23, p
= .64.
DISCUSSION
Results supported the development, preliminary efficacy, and overall
utilization of the behavioral health program. As such, the present study provides
preliminary data and evidence for establishing and maintaining a partnership between
a hospital and clinical psychology doctoral program. Results may be used to
benchmark other behavioral health integration efforts.
Program Development and Implementation
The behavioral health program was collaboratively designed and implemented,
with individuals from the hospital and the clinical psychology doctoral program. The
program and its associated clinical practicum continued to run for the third and fourth
consecutive year, respectively. The onsite clinical supervisor saw patients and
provided group and individual supervision. The practicum supervisor leads didactic
seminars and additional supervision for three-hour sessions, weekly, for the third
consecutive year. Notably, doctoral students were motivated to lead groups and
conduct individual sessions in order to accrue clinical hours and to receive intensive
training and supervision in applications of evidence-based treatments in an oncology
setting. Consistent with previous studies and recommendations for program
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development and implementation (Brothers et al., 2015; Williams et al., 2015), the
present program involved training for all clinicians, in addition to formal supervision.
Specifically, all clinicians were STAR®-certified and trained in providing evidencebased treatments (EBTs) for cancer patients.
Evaluation
The present study reports only preliminary results on program efficacy.
Specifically, administering the NCCN was challenging, as nurses were are flooded
with numerous competing clinical responsibilities, including administering
medications, fluids, and cancer treatments (including chemotherapy). As such, this
challenge may be addressed by having oncologists or support staff members
administer the NCCN during office visits. Although having nurses and oncologists
administer the measure may address some mental health stigma-related barriers,
behavioral health providers may administer this measure to all patients receiving
cancer treatment onsite, in order to maximize distress tracking. “Distress” has been
defined as a combination of anxiety and depressive symptoms, which may negatively
influence how patients cope with cancer and their ability to follow treatment
recommendations (NCCN, 2016). As such, using the NCCN is critical to providing
comprehensive cancer care, as the vast majority of cancer patients (~95%) do not
obtain psychological help (NCCN, 2016).
Administering the BAI and BDI presented even more challenges. First, only
behavioral health providers administered these measures, as these measures require
scoring and categorization into levels of severity. Additionally, the BDI item that
pertains to suicidality would require behavioral health follow-up, if endorsed by a
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patient. Second, only patients who accepted treatment completed these measures. The
majority of patients who declined to complete the BAI and BDI cited fatigue and pain
as their primary barriers. Consequently, this study lacked a control or comparison
group, as BAI and BDI scores were not available on patients who declined
psychosocial treatment.
Program Efficacy
Given challenges with BAI and BDI administration, results on changes in
anxiety and depression were limited, by the small sample size over time. Further, the
lack of a control or comparison group limited our ability to draw conclusions
regarding program efficacy. Nonetheless, these preliminary findings are promising
with regard to intervening on depression among cancer patients. Notably, the present
study not only revealed significant changes in depression between first and last session
(i.e., from mild to minimal levels of depression), but between the first and second
session (e.g., from mild to minimal levels depression). This finding is consistent with
the psychotherapy literature on large treatment gains that are often observed in the first
few sessions (Cooper, 2008). However, the present study revealed statistically
nonsignificant findings with regard to changes on anxiety. Given the unique
challenges that cancer patients are often faced with, treating anxiety might be
especially difficult. For instance, addressing concerns related to fear of tumor
progression and beginning new cancer treatments may be particularly anxietyprovoking and difficult to address (e.g., Brix et al., 2008). Nonetheless, a clinically
significant decrease in anxiety was observed (i.e., from mild to minimal levels of
anxiety).
65

Patient Demographic and Medical Characteristics
Consistent with epidemiological data on cancer incidence and prevalence, the
most common diagnosis in this study sample was breast cancer, followed by lung
cancer (National Cancer Institute, 2016). Additionally, consistent with national data,
the majority of individuals in this sample had multiple forms of treatment, often
surgery as their primary treatment, followed by chemotherapy (National Cancer
Institute, 2016).
Program Utilization
Results revealed promise with regard to behavioral health integration in a
routine cancer care setting. First, 77.8% of patients receiving cancer treatment were
offered psychosocial care. This represents a much higher proportion of patients, as
most other studies revealed substantially lower rates. For instance, Forsythe and
colleagues (2013) revealed that 55.1% of patients were never offered psychosocial
care. Notably, this study found that 50.2% patients of patients were willing to engage
in care, in contrast to another recent study that found that only 4.4% engaged in
psychosocial care (Forsythe et al., 2013). Additionally, while a previous study
reported that half of oncologists reported no affiliation with mental health services and
only 47% made a referral for psychosocial services (Muriel et al., 2015), 68.2% of
patient received a referral for onsite psychosocial treatment in this study. It is
important to note that in the present study, over a quarter (26.6%) of patients engaged
in two or more psychosocial care encounters. Finally, the present study supported the
use of STAR® referrals to increase psychosocial treatment engagement, as patients
were more likely to engage in treatment if their referral was generated through the
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STAR Program®. As such, hospitals offering cancer treatment would benefit from
acquiring STAR Program® certification.
In order to evaluate this program and its utilization more broadly, we compared
its utilization data to that of the general psychotherapy literature. First, the mean
number of sessions attended in this study was 2.77, ranging from zero to 96 sessions.
Although it is challenging to make recommendations regarding the number of therapy
sessions needed to meet criteria for remission or “recovery”, a dose-response
relationship does exist (Cooper, 2008). However, it is important to note that sudden
treatment gains on acute and symptomatic problems, as would be expected with a
cancer patient population, would tend to happen more quickly than change on more
longstanding problems (i.e., personality-based diagnoses) (e.g., Cooper, 2008; Kopta
et al., 1994). Notably, although the average number of sessions that patients engaged
in was few, research has established a ‘law of diminishing returns’, meaning that as
patients have more sessions, the added benefit of each session actually begins to
decrease (Cooper, 2008). To illustrate, research has revealed that the degree of
improvement between session 53 and 104 is approximately the same as between
sessions two and four (Cooper, 2008). The mean number of sessions attended, in the
present study, was consistent with the general psychotherapy research, which has
demonstrated that on average, patients drop out after just two sessions (Swift &
Greenberg, 2012). However, of those who engaged in treatment (n = 119) in the
present study, 42% attended three or more sessions, 10.9% attended two sessions, and
47.1% attended only one. The present research revealed that despite the unique
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challenges that cancer patients face, many committed to more than three sessions, a
number greater than what has been observed in the general psychotherapy research.
Demographics and Program Utilization
Results revealed some associations between patient demographics and use of
the behavioral health program. First, individuals who were not married were more
likely to utilize the program and to engage in two or more visits. Patients who are
married might be perceiving their spousal support as sufficient enough to decline
psychosocial treatment. Second, patients who were not employed were more likely to
accept treatment, suggesting that engaging in psychosocial care may be an additional
and demanding time commitment, given investment in work and cancer treatment. For
patients who are employed while receiving cancer treatment, providing “bedside”
psychosocial care may be especially important, in order to eliminate or minimize the
time commitment related to psychosocial care. Finally, patients who were in a younger
age group were more likely to engage in psychosocial treatment. This finding may be
interpreted in the context of mental health stigma and is consistent with previous
research findings on mental health stigma among older age groups (e.g., Brenes et al.,
2015; Conner et al., 2010; Sirey et al., 2001). Strategies to address this stigma may
include psychoeducation and having oncologists or nurses introduce behavioral health
services and its providers. Interestingly, analyses revealed no gender differences with
regard to treatment utilization. This finding is contrary to previous findings in which
men were less likely to seek or accept psychosocial care (Clement et al., 2015; Vogel
et al., 2014).
Clinical Characteristics and Program Utilization
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Results revealed some associations, with regard to patient clinical
characteristics and use of the behavioral health program. First, a relationship between
cancer diagnosis and treatment acceptance and engagement in two or more visits, was
observed, such that those with multiple cancer diagnoses, due to metastasis, were more
likely to decline treatment. Further, patients with leukemia, lung cancer, lymphoma,
multiple myeloma, pancreatic, and gastric cancer were more likely to decline
treatment. This finding may be due to decreased survival rates for the aforementioned
cancers (CDC, 2016; NIH, 2016), compared with cancers with higher survival rates
(e.g., breast), for which patients were more likely to accept psychosocial treatment.
Given that severe levels of psychological distress may interfere with coping and
cancer treatment recommendations, it may be especially important for cancer
treatment providers (oncologists, nurses) to encourage and support psychosocial care
for these individuals. Second, results revealed that patients who were receiving
chemotherapy were more likely to engage in psychosocial care than patients receiving
multiple cancer treatments (e.g., chemotherapy, radiation). Providing “bedside”
psychosocial care may address this barrier, as patients can have individual therapy
sessions while receiving chemotherapy, thereby minimizing time commitment.
Limitations and Future Directions
This study has several limitations. First, only a small subset of the sample had
baseline well-being data available. An even smaller subset of the sample had followup well-being data available. Future research should implement a systematic approach
to progress monitoring, in order to maximize well-being assessment. Second, present
findings are based on a sample that is mainly White and non-Hispanic. Given the
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differences in mental health stigma among non-White populations (Nadeem et al.,
2007), additional research examining the utilization of psychosocial services in nonWhite populations is warranted. Third, no anxiety or depression data was available on
patients who declined psychosocial care, thereby limiting our ability to compare
groups. Fourth, although the behavioral health program is a segment of the STAR®
program that sought to provide comprehensive care, this program was fundamentally
not integrated. Specifically, oncologists were often not in contact with behavioral
health providers past the initial referral, demonstrating separate, rather than integrated
care (Eickmeyer et al., 2013). This, and other programs, should seek to provide an
integrated approach, such that oncologists and behavioral health providers exchange
clinical data regarding shared patients. Conducting weekly team rounds would be an
excellent platform for exchanging crucial patient information that can inform and
tailor treatment. Despite its limitations, the study has numerous strengths and may be
used to guide future investigations and designs of behavioral health programs. First,
this program represents an important step towards improved integration of patient
care, using a multidisciplinary care approach to treatment, with enhanced access to
psychosocial services and care. Given that psychosocial care of cancer patients has
traditionally been viewed as separate from routine medical care, the present study
assessed and evaluated the implementation of a more comprehensive approach to
cancer. This study also implemented monitoring and maximization of treatment
engagement. Notably, the present investigation exemplified clinical research by
evaluating a newly developed program for cancer patients. Further, evaluation is
paramount to using data to improve and further develop a program. In sum, this data
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may be used to not only further develop the existing program, but to inform program
development in other settings. Finally, given low engagement rates, this study
underscores the importance of readiness to change, by way of engaging patients in
psychosocial care. Future studies should examine barriers to engaging in care and
should develop measures to evaluate readiness.
Conclusions
This study illustrated the feasibility of integrating a behavioral health program
into routine cancer care and generated several recommendations. First, distress
tracking may be improved by having the entire team administering measures,
including nurses, oncologists, and behavioral health providers. Second, partnerships
between clinical psychology doctoral programs and hospitals, providing cancer care,
may be mutually beneficial. Third, hospitals offering cancer treatment may benefit
from acquiring STAR® certification, in order to generate referrals for cancer care that
is more comprehensive. Treatment that incorporates psychosocial care may be used as
complementary support for patients diagnosed and treated for cancer. Taken together,
implementing these recommendations may improve patient physiological and
psychological outcomes. Finally, this study may serve as a prototype for developing
such programs and the data can benchmark the success of efforts to improve access to
cancer-related psychosocial care.

71

REFERENCES
American Cancer Society: Cancer Facts and Figures 2016. Atlanta, Ga: American
Cancer Society, 2016.
Andersen, B. L., Golden-Kreutz, D. M., Emery, C. F., & Thiel, D. L. (2009).
Biobehavioral intervention for cancer stress: conceptualization, components,
and intervention strategies. Cognitive and Behavioral Practice, 16(3), 253265.
Arnau, R. C., Meagher, M. W., Norris, M. P., & Bramson, R. (2001). Psychometric
evaluation of the Beck Depression Inventory-II with primary care medical
patients. Health Psychology, 20(2), 112.
Beck, A. T., Guth, D., Steer, R. A., & Ball, R. (1997). Screening for major depression
disorders in medical inpatients with the Beck Depression Inventory for
Primary Care. Behaviour research and therapy, 35(8), 785-791.
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988). Psychometric properties of the
Beck Depression Inventory: Twenty-five years of evaluation. Clinical
psychology review, 8(1), 77-100.
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. K. (1961). An
inventory for measuring depression. Archives of general psychiatry, 4(6), 561571.
Berkman, L. F., Blumenthal, J., Burg, M., Carney, R. M., Catellier, D., Cowan, M. J.,
...& Schneiderman, N. (2003). Effects of treating depression and low perceived
social support on clinical events after myocardial infarction: the Enhancing

72

Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.
JAMA: Journal of the American Medical Association.
Brenes, G. A., Danhauer, S. C., Lyles, M. F., Hogan, P. E., & Miller, M. E. (2015).
Barriers to mental health treatment in rural older adults. The American Journal
of Geriatric Psychiatry, 23(11), 1172-1178.
Brix, C., Schleussner, C., Füller, J., Roehrig, B., Wendt, T. G., & Strauss, B. (2008).
The need for psychosocial support and its determinants in a sample of patients
undergoing radiooncological treatment of cancer. Journal of psychosomatic
research, 65(6), 541- 548.
Brothers, B. M., Carpenter, K. M., Shelby, R. A., Thornton, L. M., Frierson, G. M.,
Patterson, K. L., & Andersen, B. L. (2015). Dissemination of an evidencebased treatment for cancer patients: training is the necessary first
step. Translational behavioral medicine, 5(1), 103-112.
Clement, S., Schauman, O., Graham, T., Maggioni, F., Evans-Lacko, S., Bezborodovs,
N., ... & Thornicroft, G. (2015). What is the impact of mental health-related
stigma on help-seeking? A systematic review of quantitative and qualitative
studies. Psychological medicine, 45(01), 11-27.
Conner, K. O., Copeland, V. C., Grote, N. K., Koeske, G., Rosen, D., Reynolds, C. F.,
& Brown, C. (2010). Mental health treatment seeking among older adults with
depression: the impact of stigma and race. The American Journal of Geriatric
Psychiatry, 18(6), 531-543.
Cooper, M. (2008). Essential research findings in counselling and psychotherapy: The
facts are friendly. Sage.
73

Eickmeyer, S., Gamble, G., Spill, G. R., & Silver, J. K. (2013). When Teams Fumble:
Cancer Rehabilitation and the Problem of the “Handoff”.
Fallowfield, L., Ratcliffe, D., Jenkins, V., & Saul, J. (2001). Psychiatric morbidity and
its recognition by doctors in patients with cancer. British journal of cancer,
84(8), 1011.
Fann, J. R., Ell, K., & Sharpe, M. (2012). Integrating psychosocial care into cancer
services. Journal of Clinical Oncology, 30(11), 1178-1186.
Forsythe, L. P., Kent, E. E., Weaver, K. E., Buchanan, N., Hawkins, N. A., Rodriguez,
J. L., ... & Rowland, J. H. (2013). Receipt of psychosocial care among
cancer survivors in the United States. Journal of Clinical Oncology, JCO2012.
Goebel, S., & Mehdorn, H. M. (2011). Measurement of psychological distress in
patients with intracranial tumours: the NCCN distress thermometer. Journal of
neuro- oncology, 104(1), 357-364.
Goodwin, P. J., Leszcz, M., Quirt, G., Koopmans, J., Arnold, A., Dohan, E., ...&
Navarro, M. (2000). Lessons learned from enrollment in the BEST study—A
multicenter randomized trial of group psychosocial support in metastatic
breast cancer. Journal of clinical epidemiology, 53(1), 47-55.
Greene, F. L., & Sobin, L. H. (2002). The TNM system: our language for cancer care.
Journal of surgical oncology, 80(3), 119-120.
Hartford, K., Wong, C., & Zakaria, D. (2002). Randomized controlled trial of a
telephone intervention by nurses to provide information and support to
patients and their partners after elective coronary artery bypass graft surgery:
74

effects of anxiety. Heart & Lung: The Journal of Acute and Critical Care,
31(3), 199-206.
Hewitt, M., Greenfield, S., & Stovall, E. (2005). Committee on Cancer Survivorship:
improving care and quality of life, Institute of Medicine and National Research
Council. From cancer patient to cancer survivor: lost in transition.
Holland, J. C., & Bultz, B. D. (2007). The NCCN guideline for distress management:
a case for making distress the sixth vital sign. Journal of the National
Comprehensive Cancer Network, 5(1), 3-7.
Jacobsen, P. B., Donovan, K. A., Trask, P. C., Fleishman, S. B., Zabora, J., Baker, F.,
& Holland, J. C. (2005). Screening for psychologic distress in ambulatory
cancer patients. Cancer, 103(7), 1494-1502.
Love, A. W., Grabsch, B., Clarke, D. M., Bloch, S., & Kissane, D. W. (2004).
Screening for depression in women with metastatic breast cancer: a
comparison of the Beck Depression Inventory Short Form and the Hospital
Anxiety and Depression Scale. Australian and New Zealand Journal of
Psychiatry, 38(7), 526-531.
Lutgendorf, S. K., & Andersen, B. L. (2015). Biobehavioral approaches to cancer
progression and survival: Mechanisms and interventions. American
Psychologist, 70(2), 186.
Manne, S., Nereo, N., DuHamel, K., Ostroff, J., Parsons, S., Martini, R., ... & Redd,
W. H. (2001). Anxiety and depression in mothers of children undergoing bone
marrow transplant: Symptom prevalence and use of the Beck Depression and

75

Beck Anxiety Inventories as screening instruments. Journal of Consulting and
Clinical Psychology, 69(6), 1037.
McCorkle, R., Ercolano, E., Lazenby, M., Schulman-Green, D., Schilling, L. S., Lorig,
K., & Wagner, E. H. (2011). Self-management: Enabling and empowering
patients living with cancer as a chronic illness. CA: A Cancer Journal for
Clinicians, 61(1), 50-62.
Mehnert, A., & Koch, U. (2008). Psychological comorbidity and health-related quality
of life and its association with awareness, utilization, and need for
psychosocial support in a cancer register-based sample of long-term breast
cancer survivors. Journal of psychosomatic research, 64(4), 383-391.
Muriel, A. C., Hwang, V. S., Kornblith, A., Greer, J., Greenberg, D. B., Temel, J., ...
& Pirl, W. (2015). Management of psychosocial distress by oncologists.
Psychiatric Services.
Nadeem, E., Lange, J. M., Edge, D., Fongwa, M., Belin, T., & Miranda, J. (2007).
Does stigma keep poor young immigrant and US-born black and Latina
women from seeking mental health care? Psychiatric Services.
National Comprehensive Cancer Network®. (2016). Managing Stress and Distress.
https://www.nccn.org/patients/resources/life_with_cancer/distress.aspx
National Cancer Institute at the National Institutes of Health. Common Cancer Types.
(2016).
Patel, D., Sharpe, L., Thewes, B., Bell, M. L., & Clarke, S. (2011). Using the distress
thermometer and hospital anxiety and depression scale to screen for

76

psychosocial morbidity in patients diagnosed with colorectal cancer. Journal
of affective disorders, 131(1), 412-416.
Purushotham, A., Bains, S., Lewison, G., Szmukler, G., & Sullivan, R. (2013). Cancer
and mental health—a clinical and research unmet need. Annals of oncology,
24(9), 2274-2278.
Shapiro, S. L., Lopez, A. M., Schwartz, G. E., Bootzin, R., Figueredo, A. J., Braden,
C. J., & Kurker, S. F. (2001). Quality of life and breast cancer: relationship to
psychosocial variables. Journal of clinical psychology, 57(4), 501-519.
Silver, J. K. (2007). Rehabilitation in women with breast cancer. Physical medicine
and rehabilitation clinics of North America, 18(3), 521-537.
Silver, J. K. (2010). Prescriptions for optimal healing. PM&R, 2(2), 94-100.
Silver, J. K. (2011). Strategies to overcome cancer survivorship care
barriers. PM&R, 3(6), 503-506.
Silver, J. K. (2013). A journey to make cancer rehabilitation the standard of
care. Work, 46(4), 473-475.
Silver, J. K., & Baima, J. (2013). Cancer prehabilitation: an opportunity to decrease
treatment-related morbidity, increase cancer treatment options, and improve
physical and psychological health outcomes. American Journal of Physical
Medicine & Rehabilitation, 92(8), 715-727.
Silver, J. K., Baima, J., & Mayer, R. S. (2013). Impairment-driven cancer
rehabilitation: An essential component of quality care and survivorship. CA: a
cancer journal for clinicians, 63(5), 295-317.

77

Silver, J. K., Baima, J., Newman, R., Galantino, M. L., & Shockney, L. D. (2013).
Cancer rehabilitation may improve function in survivors and decrease the
economic burden of cancer to individuals and society. Work, 46(4), 455-472.
Silver, J. K., & Gilchrist, L. S. (2011). Cancer rehabilitation with a focus on evidencebased outpatient physical and occupational therapy interventions. American
Journal of Physical Medicine & Rehabilitation, 90(5), S5-S15.
Silver, J., & Mayer, R. S. (2007). Barriers to pain management in the rehabilitation of
the surgical oncology patient. Journal of surgical oncology, 95(5), 427-435.
Silver, J. K., Smith, S. R., Wisotzky, E. M., Raj, V. S., Fu, J. B., & Kirch, R. A.
(2015). Response to editorial by Richard Crevenna, MD, regarding “cancer
rehabilitation and palliative care: critical components in the delivery of highquality oncology services” by Silver et al. Support Care Cancer, 23(12), 340910.
Silver, J. K., Raj, V. S., Fu, J. B., Wisotzky, E. M., Smith, S. R., & Kirch, R. A.
(2015). Cancer rehabilitation and palliative care: critical components in the
delivery of high-quality oncology services. Supportive Care in
Cancer, 23(12), 3633-3643.
Silver, J. K. (2014). Cancer rehabilitation and prehabilitation may reduce disability
and early retirement. Cancer, 120(14), 2072-2076.
Silver, J. K. (2015, February). Cancer prehabilitation and its role in improving health
outcomes and reducing health care costs. In Seminars in oncology
nursing (Vol. 31, No. 1, pp. 13-30). WB Saunders.

78

Sirey, J. A., Bruce, M. L., Alexopoulos, G. S., Perlick, D. A., Raue, P., Friedman, S.
J., & Meyers, B. S. (2001). Perceived stigma as a predictor of treatment
discontinuation in young and older outpatients with depression. American
Journal of Psychiatry, 158(3), 479-481.
Söllner, W., DeVries, A., Steixner, E., Lukas, P., Sprinzl, G., Rumpold, G., &
Maislinger, S. (2001). How successful are oncologists in identifying patient
distress, perceived social support, and need for psychosocial counselling?
British Journal of Cancer, 84(2), 179.
Stanton, A. L., Luecken, L. J., MacKinnon, D. P., & Thompson, E. H. (2013).
Mechanisms in psychosocial interventions for adults living with cancer:
Opportunity for integration of theory, research, and practice. Journal of
consulting and clinical psychology, 81(2), 318.
Swift, J. K., & Greenberg, R. P. (2012). Premature discontinuation in adult
psychotherapy: a meta-analysis. Journal of consulting and clinical
psychology, 80(4), 547.
Vargo MM. The oncology-rehabilitation interface: Better systems needed. J Clin
Oncol. 2008;26(16):2610-1.
Vogel, D. L., Wester, S. R., Hammer, J. H., & Downing-Matibag, T. M. (2014).
Referring men to seek help: The influence of gender role conflict and
stigma. Psychology of Men & Masculinity, 15(1), 60.
Williams, K. C., Brothers, B. M., Ryba, M. M., & Andersen, B. L. (2015).
Implementing evidence-based psychological treatments for cancer
patients. Psycho-Oncology, 24(12), 1618-1625.
79

Woltmann, E., Grogan-Kaylor, A., Perron, B., Georges, H., Kilbourne, A. M., &
Bauer, M.S. (2012). Comparative effectiveness of collaborative chronic care
models for mental health conditions across primary, specialty, and behavioral
health care settings: systematic review and meta-analysis. American Journal
of Psychiatry, 169(8), 790-804.
Zabora, J., Brintzenhofeszoc, K., Curbow, B., Hooker, C., & Piantadosi, S. (2001).
The prevalence of psychological distress by cancer site. PsychoOncology, 10(1), 19-28.

80

Table 1.
Baseline Characteristics
Variable
Sex
Female
Male
Other
Age
18-34
35-49
50-64
65+
Race/Ethnicity
White
Multiracial/Other
Black
Native American
Asian/Pacific Islander
Hispanic/Latino
Middle Eastern
Marital Status
Married
Not married
Divorced
Widowed
Not Reported
Living with partner
Separated
Employment Status
Retired
Not Reported
Employed
Disabled/On Leave
Unemployed
Student

Participants
% (n)
54.2% (n=129)
45.4% (n=108)
.4% (n=1)
1.9% (n=4)
6% (n=13)
35.8% (n=77)
56.3% (n=121)
85.7% (n=204)
11.8% (n=28)
.8% (n=2)
.4% (n=1)
.4% (n=1)
.4% (n=1)
.4% (n=1)
59.2% (n=141)
13.1% (n=31)
11.3% (n = 27)
8.8% (n=21)
4.6% (n=11)
2.1% (n=5)
0.8% (n=2)
34.5% (n=82)
33.6% (n=80)
16% (n=38)
9.6% (n=23)
5.5% (n=13)
0.8% (n = 2)
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Table 2.
Clinical Characteristics.
Variable

Participants

STAR Referral
Yes
No
Cancer Site
Breast
Digestive/Gastrointestinal
Endocrine/Neuroendocrine
Genitourinary
Gynecologic
Head & Neck
Hematologic/Blood
Musculoskeletal
Neurologic
Respiratory/Thoracic
Skin
Unknown Primary
Metastasized
Cancer Stage
0
I
II
III
IV
Unknown
Hematologic
Treatment type
Chemotherapy
Homeopathy
Immunotherapy
Targeted Therapy
Radiation
Surgery
2 treatments
3+ treatments

% (n)
68.2% (n=150)
31.9% (n=70)
19.5% (n=43)
16% (n=35)
1.3% (n=3)
4.6% (n=10)
2.3% (n=5)
5% (n=11)
13.6% (n=30)
0.5% (n=1)
1.8% (n=4)
11.4% (n=25)
1% (n=2)
4.1% (n=9)
19.1% (n=42)
8.5% (n=17)
15.6% (n=31)
14.1% (n=28)
14.6% (n=29)
29.6% (n=59)
13.6% (n=25)
4% (n=8)
63.8% (n=127)
.5% (n=1)
.5% (n=1)
.5% (n = 1)
5% (n=10)
7.54% (n=15)
21.1% (n = 42)
1% (n = 2)

*Note. Caregivers were not included in the treatment type analysis
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Figure 1. Flowchart for Referral Process
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Figure 2.
Depression and Anxiety Scores across Sessions

17
16
BDI
15

BAI

14

Scores

13
12
11
10
9
8
Session 1

Session 2

Final Session

Note. Total BDI and BAI scores across three time points. The solid line shows the
depression scores, while the dashed line shows the anxiety scores. Change in
depression scores was significant between the first and second session and between
the first and final session. Change in anxiety scores was neither significant between
the first and second session, nor between the first and final session.
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